⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18925263 | 1.00 | — | — | |
| SCHEMBL18925257 | 0.75 | — | — | |
| SCHEMBL4331044 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL4330490 | 0.73 | — | — | |
| SCHEMBL5967284 | 0.73 | — | — | |
| Bicarbonate SCHEMBL27732642 | 0.71 | — | — | |
| Bicarbonate SCHEMBL27732671 | 0.71 | SLC1A3 (0.48) | — | |
| SCHEMBL24225951 | 0.71 | — | — | |
| SCHEMBL303947 | 0.71 | — | — | |
| Alanine SCHEMBL5676881 | 0.71 | SLC1A3 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-6192076-A | — | — | None | — | — | JP | disclosed |
| EP-4504732-A2 | NANOMATERIAL DELIVERY VEHICLE AND METHOD OF USE THEREOF | University of Connecticut (US) | 2025-02-12 | — | — | EP | disclosed |
| CN-118879592-A | Unnatural base pair compositions and methods of use | 斯克利普斯研究所 | 2024-11-01 | — | — | CN | disclosed |
| EP-4422693-A1 | TRANS-CYCLOOCTENE CONJUGATES | Tambo, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| CN-112105627-B | Unnatural base pair compositions and methods of use | 斯克利普斯研究所 | 2024-07-02 | — | — | CN | disclosed |
| CN-118139868-A | Orally bioavailable nucleoside analogs | 维纳拓尔斯制药公司 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024083220-A1 | LIGAND-OLIGONUCLEOTIDE CONJUGATE AND LINKER FOR CONJUGATE | 上海京新生物医药有限公司 | 2024-04-25 | — | — | WO | disclosed |
| US-20240131032-A1 | AN ACTIVITY-GUIDED MAP OF ELECTROPHILE-CYSTEINE INTERACTIONS IN PRIMARY HUMAN IMMUNE CELLS | THE SCRIPPS RESEARCH INSTITUTE | 2024-04-25 | — | — | US | disclosed |
| EP-4355755-A1 | ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS | Venatorx Pharmaceuticals, Inc. (US) | 2024-04-24 | — | — | EP | disclosed |
| US-20240123078-A1 | COMPOUNDS AND METHODS FOR MODULATING IMMUNE-RELATED PROTEINS | VIVIDION THERAPEUTICS, INC. | 2024-04-18 | — | — | US | disclosed |
| US-20130123169-A1 | PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2013-05-16 | — | — | US | disclosed |
| US-8367368-B2 | D-serine dehydratase and use thereof | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20120244520-A1 | D-SERINE DEHYDRATASE AND USE THEREOF | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2012-09-27 | — | — | US | disclosed |
| US-20010049392-A1 | Inhibition of IgA production | TAKARA SHUZO CO., LTD. (JP) | 2001-12-06 | — | — | US | disclosed |
| US-6294581-B1 | ORALLY ADMINISTERING 15-DEOXYSPERGUALIN OR ITS SALT FOR SELECTIVELY SUPPRESSION IMMUNOGLOBULIN A | TAKARA SHUZO CO., LTD. (JP) | 2001-09-25 | — | — | US | disclosed |
| EP-1080723-A1 | INHIBITION OF IgA PRODUCTION | Takara Shuzo Co, Ltd. (JP) | 2001-03-07 | — | — | EP | disclosed |
| EP-1076649-A1 | ISOQUINOLINE COMPOUND MELANOCORTIN RECEPTOR LIGANDS AND METHODS OF USING SAME | TREGA BIOSCIENCES, INC. (US) | 2001-02-21 | — | — | EP | disclosed |
| US-6127381-A | A MELANOCORTIN RECEPTOR LIGAND FOR REGULATING FOOD INTAKE AND BODY WEIGHT, REGULATING CYTOKINE ACTIVITY, ANTI-INFLAMMATORY ACTIVITY | LION BIOSCIENCE AG (DE) | 2000-10-03 | — | — | US | disclosed |
| WO-1999055679-A1 | ISOQUINOLINE COMPOUND MELANOCORTIN RECEPTOR LIGANDS AND METHODS OF USING SAME | TREGA BIOSCIENCES, INC. (US) | 1999-11-04 | — | — | WO | disclosed |
| JP-H06192076-A | ANTIPROTOZOAL | NIPPON KAYAKU CO LTD | 1994-07-12 | — | — | JP | disclosed |